Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation

Transfusion

Volumn 51, Issue 7, 2011, Pages 1397-1404

  Fast, Loren D ^a,b   Dileone, Gilbert ^a,b   Marschner, Susanne ^a,b  

^a BROWN UNIVERSITY   (United States)

^b CaridianBCT Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; LIPOPOLYSACCHARIDE;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA IRRADIATION; INTERMETHOD COMPARISON; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MEDICAL TECHNOLOGY; PATHOGEN REDUCTION TECHNOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; T LYMPHOCYTE; THROMBOCYTE;

BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD TRANSFUSION; CELL PROLIFERATION; DISINFECTION; GAMMA RAYS; HUMANS; IMMUNE SYSTEM PROCESSES; LEUKOCYTE REDUCTION PROCEDURES; LEUKOCYTES;

EID: 79851485222     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02984.x     Document Type: Article

References (24)

1. Vamvakas EC, Blajchman MA,. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327-48. (Pubitemid 47498679)
2. Vamvakas EC, Blajchman MA,. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
3. Hendrickson JE, Hillyer CD,. Noninfectious serious hazards of transfusion. Anesth Analg 2009; 108: 759-69.
4. Dwyre DM, Holland PV,. Transfusion-associated graft-versus-host disease. Vox Sang 2008; 95: 85-93. (Pubitemid 351951899)
5. Luban NL, Drothler D, Moroff G, Quinones R,. Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion 2000; 40: 348-52. (Pubitemid 30171687)
6. Pelszynski MM, Moroff G, Luban NL, Taylor BJ, Quinones RR,. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994; 83: 1683-9. (Pubitemid 24081586)
7. King KE, Shirey RS,. Transfusion management of patients with sickle cell disease: the continuing dilemma. Transfusion 2010; 50: 2-4.
8. Shaz BH, Zimring JC, Demmons DG, Hillyer CD,. Blood donation and blood transfusion: special considerations for African Americans. Transfus Med Rev 2008; 22: 202-14. (Pubitemid 351842624)
9. Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, Constantini LA, Patterson B, Roberts RS, Thorpe KE, Levine MN,. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002; 42: 556-66.
10. Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL,. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004; 44: 16-24. (Pubitemid 38177131)
11. Yazer MH, Podlosky L, Clarke G, Nahirniak SM,. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004; 44: 10-5. (Pubitemid 38177130)
12. Muylle L, Peetermans ME,. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994; 66: 14-7. (Pubitemid 24017151)
13. Heddle NM,. Universal leukoreduction and acute transfusion reactions: putting the puzzle together. Transfusion 2004; 44: 1-4. (Pubitemid 38177128)
14. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME,. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion 1993; 33: 195-9. (Pubitemid 23073640)
15. Fast L, DiLeone G, Cardarelli G, Li J, Goodrich R,. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion 2006; 46: 1553-60. (Pubitemid 44326331)
16. Fast L, DiLeone G, Li J, Goodrich R,. Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006; 46: 642-6.
17. Taswell C,. Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model. J Immunol Methods 1984; 72: 29-40. (Pubitemid 14091991)
18. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG,. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 625-8. (Pubitemid 24276861)
19. Luban N,. Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components. Semin Hematol 2001; 38: 34-45. (Pubitemid 33096557)
20. Ohto H,. Gamma radiation does not prevent transfusion-induced HLA alloimmunization. Transfusion 1997; 37: 878-9. (Pubitemid 27369143)
21. Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O,. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 2006; 46: 800-10.
22. Picker S, Steisel A, Gathof B,. Evaluation of white blood cell- and platelet-derived cytokine accumulation in MIRASOL-PRT-treated platelets. Trans Med Hemoth 2009; 36: 114-20.
23. Fujihara M, Ikebuchi K, Wakamoto S, Sekiguchi S,. Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-beta1 in apheresis platelet concentrates during storage. Transfusion 1999; 39: 498-505. (Pubitemid 29233274)
24. Kluter H, Bubel S, Kirchner H, Wilhelm D,. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39: 1179-84.